RxDoctor Payments Data

Robert Maxwell, MD

Surgery · Chattanooga, TNNPI 1982698627

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,068 of the $7,378 with a category attached, or 68.7%. It is spread thinly across 22 manufacturers, the largest accounting for just 23.4%.

$7,378in general payments, 2019–2025

Across 81 payments — averaging $91.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$2K
  • Steris Corporation$2K
  • Intuitive Surgical$1K
  • Medical Device Business Services, Inc.$1K
  • Johnson & Johnson$478
  • Smith+Nephew$240
  • plus $752 from 16 others
$385,779in research payments, 2019–2025

Across 23 payments — averaging $16,773 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$386K

What the payments were for

  • Travel & lodging$5,06869%
  • Food & beverage$2,31031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,378 in reported general payments places this provider in the 70th percentile of 516 surgery providers in Tennessee.

See all surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$153,441
Medicare patients
388
Services billed
905

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$41

Paid to pharmacies, not to this prescriber.

Other surgery in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →